Loncar Cancer Immunothera... (CNCR)
NASDAQ: CNCR
· Real-Time Price · USD
9.02
0.14 (1.58%)
At close: May 27, 2025, 3:57 PM
CNCR Holdings List
As of Apr 17, 2023
The Loncar Cancer Immunotherapy ETF is an equity ETF with a total of 30 individual holdings.
The top holdings are Instil Bio at 3.59%, Replimune at 3.54%, Iovance Biotherapeutics at 3.47%, Zymeworks at 3.45%, and Genmab A/S at 3.42%.
30
34.43%
Equity
12.73M
n/a
0.7900%
Sector Allocation
| Rank | Symbol | Name | Price | % Change | Shares | % Weight |
|---|---|---|---|---|---|---|
| 1 | TIL | Instil Bio, Inc... | 18.47 | +9.10% | 93.23K | 3.59% |
| 2 | REPL | Replimune Group... | 4.34 | +5.08% | 47.19K | 3.54% |
| 3 | IOVA | Iovance Biother... | 2.23 | +5.69% | 67.48K | 3.47% |
| 4 | ZYME | Zymeworks Inc. | 17.23 | +3.80% | 41.55K | 3.45% |
| 5 | GMAB | Genmab A/S | 29.33 | +0.89% | 35.79K | 3.42% |
| 6 | ARGX | argenx SE | 719.04 | +1.04% | 5.06K | 3.42% |
| 7 | CRSP | CRISPR Therapeu... | 63.77 | +3.41% | 12.62K | 3.39% |
| 8 | BMY | Bristol-Myers S... | 44.12 | +0.01% | 23.17K | 3.39% |
| 9 | AZN | AstraZeneca PLC | 74.13 | +0.50% | 26.54K | 3.39% |
| 10 | NKTR | Nektar Therapeu... | 58.92 | +0.72% | 87.53K | 3.37% |
| 11 | MRK | Merck & Co., In... | 78.58 | +0.02% | 20.51K | 3.37% |
| 12 | XNCR | Xencor, Inc. | 11.55 | -0.17% | 41.93K | 3.37% |
| 13 | REGN | Regeneron Pharm... | 560.75 | -0.56% | 2.94K | 3.36% |
| 14 | FATE | Fate Therapeuti... | 1.00 | -0.01% | 17.66K | 3.33% |
| 15 | GILD | Gilead Sciences... | 112.62 | +0.46% | 22.54K | 3.33% |
| 16 | RCUS | Arcus Bioscienc... | 13.31 | +3.66% | 62.77K | 3.32% |
| 17 | ATRA | Atara Biotherap... | 13.81 | +0.51% | 108.6K | 3.30% |
| 18 | ALLO | Allogene Therap... | 1.27 | +1.60% | 60.62K | 3.29% |
| 19 | RUBY | Rubius Therapeu... | 0.06 | +2.70% | 59.29K | 3.29% |
| 20 | TRIL | Trillium Therap... | 18.44 | 0.00% | 160.99K | 3.29% |
Page 1 of 2